Citigroup Inc Editas Medicine, Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Citigroup Inc holds 8,359 shares of EDIT stock, worth $22,234. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,359

Previous 59,885 86.04%

Holding current value

$22,234

Previous $131,000 77.86%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$2.2 - $3.52 $113,357 - $181,371	-51,526 Reduced 86.04%	8,359 $29,000
Q2 2025 Aug 11, 2025	SELL	$0.98 - $2.35 $3,206 - $7,689	-3,272 Reduced 5.18%	59,885 $131,000
Q1 2025 May 12, 2025	SELL	$1.14 - $3.2 $40,978 - $115,027	-35,946 Reduced 36.27%	63,157 $73,000
Q4 2024 Feb 12, 2025	BUY	$1.2 - $3.76 $40,041 - $125,463	33,368 Added 50.76%	99,103 $125,000
Q3 2024 Nov 12, 2024	SELL	$3.39 - $5.96 $400 - $703	-118 Reduced 0.18%	65,735 $224,000
Q2 2024 Aug 12, 2024	SELL	$4.67 - $7.28 $2.92 Million - $4.56 Million	-626,080 Reduced 90.48%	65,853 $307,000
Q1 2024 May 10, 2024	BUY	$7.03 - $11.07 $3.81 Million - $6 Million	541,839 Added 361.0%	691,933 $5.13 Million
Q4 2023 Feb 09, 2024	SELL	$6.25 - $11.11 $390,550 - $694,241	-62,488 Reduced 29.39%	150,094 $1.52 Million
Q3 2023 Nov 09, 2023	BUY	$6.92 - $9.31 $176,681 - $237,702	25,532 Added 13.65%	212,582 $1.66 Million
Q2 2023 Aug 10, 2023	SELL	$6.36 - $11.47 $2.83 Million - $5.11 Million	-445,421 Reduced 70.43%	187,050 $1.54 Million
Q1 2023 May 11, 2023	BUY	$7.03 - $11.53 $2.01 Million - $3.3 Million	286,589 Added 82.86%	632,471 $4.59 Million
Q4 2022 Feb 09, 2023	SELL	$8.32 - $13.21 $680,709 - $1.08 Million	-81,816 Reduced 19.13%	345,882 $3.07 Million
Q3 2022 Nov 10, 2022	SELL	$12.16 - $19.42 $736,519 - $1.18 Million	-60,569 Reduced 12.4%	427,698 $5.24 Million
Q2 2022 Aug 10, 2022	BUY	$9.99 - $21.35 $4.05 Million - $8.65 Million	405,097 Added 487.07%	488,267 $5.78 Million
Q1 2022 May 12, 2022	SELL	$14.08 - $27.63 $1.41 Million - $2.77 Million	-100,275 Reduced 54.66%	83,170 $1.58 Million
Q4 2021 Feb 10, 2022	BUY	$26.55 - $40.57 $3.01 Million - $4.6 Million	113,444 Added 162.06%	183,445 $4.87 Million
Q3 2021 Nov 10, 2021	BUY	$39.27 - $72.94 $2.75 Million - $5.11 Million	70,001 New	70,001 $2.88 Million

Others Institutions Holding EDIT

# of Institutions

211

Shares Held

45.8M

Call Options Held

486K

Put Options Held

338K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $183M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account